Resources

This user guide supports prescribers in all healthcare settings to adopt active ingredient prescribing.

Use this form to submit a request for consideration of a specific medicine for inclusion in the List of Excluded Medicinal Items (LEMI) or List of Medicines for Brand Consideration (LMBC).

This snapshot shows this initiative at a glance. It includes budgets, early funding priorities and grant timelines, as of November 2019. Researchers and other stakeholders can use it to plan for upcoming opportunities and see how the initiative will be established, expanded and embedded over time.

The Government announced a $5 billion, 10-year investment plan for the MRFF as part of its 2019–20 Budget. This plan continues our support for lifesaving research, gives researchers and industry certainty and direction, and reaffirms Australia’s reputation as a world leader in medical research.